Abstract

The development of transgenic and knockout technologies has driven an explosion in new animal models of disease. These engineered diseases are a departure from previous animal models in that pathological syndromes are created froma prioriassumptions about how disease pathogenesis could develop. Such models have been useful in providing new information on the functions of effector molecules such as cytokines, and in following the behavior of lymphocytesin vivo.However, the contrived nature of the systems might generate false information, unless validated by careful reference to human disease and spontaneous disease in other animal models.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call